Oramed Pharmaceuticals

ORMP58

High Value

$2.23arrow_drop_down2.99%-$0.06

High Value

Penny Stock

ORMP58

$2.23

arrow_drop_down2.99%-$0.06

High Value

Penny Stock

Performance History

Key Stats
Open	$2.31
Prev. Close	$2.32
EPS	0.51
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$95.19M

	LOW	HIGH
Day Range	2.31	2.38
52 Week Range	1.67	3.67

Ratios







EPS	0.51

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc (ORMP) is a biopharmaceutical company focused on the development of oral drug delivery systems. The company has developed a proprietary oral insulin capsule, which is currently in advanced stages of clinical trials. The capsule is designed to replace injectable insulin for the treatment of diabetes. This innovative approach has the potential to revolutionize the way diabetes is managed, providing a more convenient and patient-friendly option for insulin delivery.

The stock price history of Oramed Pharmaceuticals Inc has shown significant volatility over the past few years. The company has experienced both ups and downs, reflecting the uncertainties associated with clinical trials and regulatory approvals. However, recent positive developments, such as successful completion of late-stage clinical trials, have boosted investor confidence and led to a significant increase in the stock price.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Nadav Kidron Esq.
Headquarters: New York
Employees: 0
Exchange: NASDAQ

Keep an eye on Oramed Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Oramed Pharmaceuticals 's (ORMP) price per share?

The current price per share for Oramed Pharmaceuticals (ORMP) is $2.23. The stock has seen a price change of -$0.07 recently, indicating a -3% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Oramed Pharmaceuticals (ORMP)?

For Oramed Pharmaceuticals (ORMP), the 52-week high is $3.67, which is 64.57% from the current price. The 52-week low is $1.67, the current price is 33.53% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Oramed Pharmaceuticals (ORMP) a growth stock?

Oramed Pharmaceuticals (ORMP) has shown an average price growth of -4.94% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Oramed Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Oramed Pharmaceuticals (ORMP) stock price performance year to date (YTD)?

As of the latest data, Oramed Pharmaceuticals (ORMP) has a year-to-date price change of -8.98%. Over the past month, the stock has experienced a price change of -6.3%. Over the last three months, the change has been -0.45%. Over the past six months, the figure is -9.72%. Looking at a longer horizon, the five-year price change stands at -11.16%.

help

Is Oramed Pharmaceuticals (ORMP) a profitable company?

Oramed Pharmaceuticals (ORMP) has a net income of $5.52M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.34M, although specific revenue growth data is currently not available. Operating income is noted at -$15.77M. Furthermore, the EBITDA is -$12.85M.

help

What is the market capitalization of Oramed Pharmaceuticals (ORMP)?

Oramed Pharmaceuticals (ORMP) has a market capitalization of $90.91M. The average daily trading volume is 2.28, indicating the stock's liquidity and investor engagement.